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Fibres with a range of abilities to perturb cholesterol homeostasis were used to investigate how the serum cholesterol-lowering effects of insoluble dietary
fibres are related to parameters of intestinal cholesterol absorption and hepatic cholesterol homeostasis in mice. Cholestyramine, chitosan and cellulose were
used as examples of fibres with high, intermediate and low bile acid-binding capacities, respectively. The serum cholesterol levels in a control group of mice
fed a high fat/high cholesterol (HFHC) diet for 3 weeks increased about 2-fold to 4·3 mM and inclusion of any of these fibres at 7·5 % of the diet prevented
this increase from occurring. In addition, the amount of cholesterol accumulated in hepatic stores due to the HFHC diet was reduced by treatment with these
fibres. The three kinds of fibres showed similar hypocholesterolaemic activity; however, cholesterol depletion of liver tissue was greatest with cholestyr-
amine. The mechanisms underlying the cholesterol-lowering effect of cholestyramine were (1) decreased cholesterol (food) intake, (2) decreased cholesterol
absorption efficiency, and (3) increased faecal bile acid and cholesterol excretion. The latter effects can be attributed to the high bile acid-binding capacity of
cholestyramine. In contrast, incorporation of chitosan or cellulose in the diet reduced cholesterol (food) intake, but did not affect either intestinal cholesterol
absorption or faecal sterol output. The present study provides strong evidence that above all satiation and satiety effects underlie the cholesterol-lowering
properties of insoluble dietary fibres with moderate or low bile acid-binding capabilities.
Dietary fibres: Cholesterol-lowering: Intestinal cholesterol absorption: Bile acid
Studies with animals and human subjects indicate that there is a
considerable inter-individual variation in the rate of dietary choles-
terol absorption in the small intestine (Grundy, 1983; Sehayek et al.
1998). Furthermore, intestinal cholesterol absorption efficiency is
positively correlated with plasma cholesterol levels (Kesaniemi &
Miettinen, 1987) and plasma cholesterol level is positively corre-
lated with the incidence of CHD (Castelli, 1984). It follows that a
reduction of cholesterol absorption in the small intestine should
be beneficial in the prevention of CHD. In light of this, there has
been great interest in the influence of food constituents, such as diet-
ary fibres, on cholesterol absorption in the intestine.
Dietary fibres are non-digestible, water-soluble or water-insolu-
ble carbohydrates that are present in the diet and are claimed to
have beneficial effects in the lowering of serum cholesterol and
the prevention of CHD (Story et al. 1997; Fernandez, 2001).
The exact in vivo mechanisms for the lowering of serum and
hepatic cholesterol levels by naturally occurring fibres are not
well understood. On the other hand, the principal mechanism of
action of the pharmacological agent, cholestyramine, is well
known. This cationic polymer acts through the sequestration of
bile acids in the intestine, resulting in an interruption of the enter-
ohepatic circulation of bile acids and an up-regulation of bile acid
synthesis (Casdorph, 1967). Moreover, the sequestration of bile
acids is likely to perturb the process of intestinal cholesterol
absorption, and a decrease in cholesterol absorption efficiency
by cholestyramine feeding has been established in various
animal models, as well as in man (Gylling et al. 1989).
The aim of our studies was to use a mouse model to investigate
the hypocholesterolaemic effects of insoluble dietary fibres. We
examined three fibres that possess a range of abilities to perturb
bile acid and sterol metabolism. The bile acid resin cholestyra-
mine (a styrene–divinylbenzene copolymer containing quaternary
ammonium groups) was included as a positive control, as it is a
potent anion exchanger with a high bile acid-binding capacity.
Chitosan was used because it has weak anion exchange proper-
ties; from in vitro studies, it was concluded that chitosan has
about 50 % of the bile acid-binding capacity of cholestyramine
(Lee et al. 1999). Chitosan is the deacetylated form of chitin,
which is N-acetylaminocellulose present in the exoskeleton of
arthropods and is considered a fibre of animal origin (Furda,
1983). Cellulose (an unbranched polymer of b-1,4-linked glucose
residues) is a common dietary fibre that is uncharged and has little
or no bile acid-binding capacity (Vahouny et al. 1980a,b).
Our investigations focused on how the serum cholesterol-low-
ering effects of insoluble dietary fibres are related to parameters
of intestinal cholesterol absorption, an aspect that has
not received much attention yet, and hepatic cholesterol
homeostasis.
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Experimental methods
Animals and diets
Female C57BL/6 mice, aged 8–12 weeks, were obtained from the
Jackson Laboratories (Bar Harbor, ME, USA). The mice were
housed three per cage in the Laboratory Animal Facility in a tem-
perature- and humidity-controlled room with a 12 h light–dark
cycle. They were fed a standard rodent chow (5P84 diet, North
Penn Feeds, Hatfield, PA, USA) until the start of the dietary treat-
ment. Subsequently, the mice were divided into four groups of
six: the first group (control) was fed a high fat/high cholesterol
(HFHC) diet containing no added fibre for 3 weeks while the
other three groups were fed the same HFHC diet containing
either 7·5 % (w/w) cholestyramine, 7·5 % chitosan (i.e. chitin
which is minimally 85 % deacetylated) or 7·5 % cellulose. This
dietary inclusion level of 7·5 % (w/w) was chosen to ensure that
chitosan would be effective in lowering serum cholesterol level
without having any side-effects (Han et al. 1999). The HFHC
diet (obtained from North Penn Feeds) consisted of Purina
Mouse Chow, 5015; meal: 750 g/kg; casein, high protein: 75 g/
kg; dextrose, monohydrate: 25 g/kg; sucrose: 16·25 g/kg; dextrin:
16·25 g/kg; cocoa butter: 75 g/kg; cholesterol: 12·5 g/kg; sodium
cholate: 5 g/kg; cellulose (fibre): 12·5 g/kg; mineral mix, AIN-
76: 8·75 g/kg; vitamin mix, AIN 76A(sub): 2·5 g/kg; choline
chloride: 1·25 g/kg. The fibres were ground into the diet with a
mortar and pestle and, after the addition of distilled water, new
pellets were made and dried. Cholestyramine (cat. no. C-4650),
chitosan (cat. no. C-3646) and cellulose (cat. no. C-6413) were
obtained from Sigma Chemical Co. (St Louis, MO, USA).
Body weight (each mouse individually), food intake (averages
of three mice) and the general appearance of the mice were
recorded three times a week.
Intestinal cholesterol absorption
At the end of the 3-week feeding period, animals were transferred to
metabolic cages in the afternoon before the cholesterol uptake
experiment. The following morning, the mice were fasted for 6 h,
and 2 h before the start of the dark cycle they were gavaged
100ml corn oil containing 1mCi [14C]cholesterol ([4-14C]choles-
terol, 45–60 mCi/mmol; NEN Life Science Products, Boston,
MA, USA) and 0·4mCi (8 pmol) [3H]ab-sitostanol ([5,6-3H]ab-
sitostanol 50 Ci/mmol; American Radiolabeled Chemicals,
St Louis, MO, USA). For this, aliquots of [14C]cholesterol and
[3H-ab]sitostanol were dissolved in ethanol and mixed with corn
oil, and the ethanol was subsequently removed by slowly bubbling
N2 through the solution for 3–4 h. Prior to use, the purity of the
radiolabelled lipids was assessed by TLC and was at least 95 %
for [3H]ab-sitostanol and at least 98 % for [14C]cholesterol. After
receiving the gavage, each mouse was returned to its metabolic
cage where it immediately started to eat chow. Faeces were col-
lected for 24 h periods, up to 72 h. Animals were anaesthetized
using an intraperitoneal injection of a mixture of 150 mg ketamine
plus 10 mg xylazine (Research Biomedical Instruments, Natick,
MA, USA) per kg body weight. When killed, blood, gall bladder
bile and liver were harvested for further analyses. Sera were
obtained after clotting of the blood and centrifugation. All animal
studies were approved by the Institutional Animal Care and Use
Committee of the Children’s Hospital of Philadelphia.
Analytical methods
Total collected faeces were weighed and homogenized in water
(10 %, w/v). Sterols were extracted from an aliquot of an appropriate
dilution of the homogenate with an equal volume of chloroform–
methanol (2:1, v/v), and [14C]cholesterol and [3H]ab-sitostanol
were determined by liquid scintillation counting. Appropriate stan-
dards were used to correct for spillover between the 3H- and 14C-
counting channels. The cholesterol absorption efficiency was deter-
mined by the faecal dual-isotope ratio method (Grundy et al. 1968).
Faecal cholesterol levels, and serum and biliary cholesterol levels
were measured enzymatically using Sigma Diagnostics commercial
kit no. 352, and biliary bile acid levels were determined using Sigma
Diagnostics commercial kit no. 450-A, following the instructions of
the manufacturer (Sigma Chemical Co.). For biliary bile acid ana-
lysis, a mixture of cholic acid and taurocholic acid (1:1 molar
ratio) was used as a standard. Biliary phospholipids were deter-
mined using a phosphorus assay (Bartlett, 1959). Hepatic free
cholesterol and total cholesterol were determined by GLC (Ishikawa
et al. 1974) using cholesteryl methyl ether as an internal standard.
Cholesteryl ester content was calculated as the difference between
total and free cholesterol content. Bile acids were extracted from
faeces essentially as described by Schiller et al. (1990). Briefly,
0·4 ml of an eight times dilution of a 10 % faecal homogenate
were added to a test tube containing 0·2 ml 10 M-NaOH and 2 ml
100 % ethanol. An internal standard of 0·2mCi (0·2 nmol) of
[3H(G)]taurocholic acid (2 Ci/mmol; NEN Life Science Products)
was then added and the samples were refluxed on a heating block
at 95–1008C for 1 h. Appropriate standards of a 1:1 molar mixture
of cholic acid and taurocholic acid were treated similarly. After
refluxing, samples were centrifuged for 15 min at 1500 g. Neutral
sterols were extracted from two 0·5 ml aliquots of each sample
supernatant using 0·75 ml petroleum ether three times. The remain-
ing water–ethanol phase was evaporated and the residue redis-
solved in 0·5 ml water, after which the pH was adjusted to 7 using
1 M-HCl. Samples were dried and the residue was dissolved in
methanol–Tris-HCl buffer (0·13 M-Tris-HCl, 0·67 mM-ethylene
diamine tetraacetic acid, pH 9·5) (3·75:6·25, v/v). Aliquots were
taken for liquid scintillation counting and bile acid analysis using
the enzymatic assay of Turley & Dietschy (1978).
Statistical analysis
Statistical evaluation was performed on a personal computer
using Excel, Statistica version 6 (correlations; Statsoft Inc.,
Tulsa, OK, USA) and SPSS version 11.5 (SPSS, Chicago, IL,
USA). Results are expressed as mean values and standard devi-
ations. Variables were compared between the group of control
animals and each group of fibre-treated animals by ANOVA fol-
lowed by the two-sided Dunnett test.
Results
Effects of dietary fibres on cholesterol concentrations in the
serum and liver
Table 1 shows the effects of the dietary fibres on serum choles-
terol levels in female C57BL/6 mice after changing their diet
from standard rodent chow to a HFHC diet containing 7·5 %
cocoa butter and 1·25 % cholesterol. In control animals fed the
HFHC diet without any of the three added fibres, the serum
cholesterol level averaged 4·2 mM, consistent with published
data (Carter et al. 1997). Upon feeding for 3 weeks with a
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HFHC diet containing 7·5 % cholestyramine, chitosan or cellu-
lose, serum cholesterol levels were significantly lower with aver-
age values of 2·0, 2·2 and 1·6 mM, respectively. These values are
similar to those obtained when the mice were fed a standard lab-
oratory chow without added fat and cholesterol (data not shown).
Thus, inclusion of any of the fibres in the diet prevented the
increase in serum cholesterol level normally seen when the fat
and cholesterol content of the diet is raised.
Hepatic steady-state sterol levels were determined as total choles-
terol and as cholesteryl ester in all four groups of mice. When cho-
lestyramine was included in the diet, the amount of total cholesterol
did not increase to 72 mg cholesterol/g liver as observed with con-
trol animals fed a HFHC diet but remained low, i.e. 2·9 mg choles-
terol/g liver (Table 1). Similar levels of liver cholesterol to the latter
figure were observed when mice were fed a standard laboratory
chow with no added fat and cholesterol (data not shown). Similar
decreases in hepatic cholesterol stores have been reported in
animal feeding studies using cholestyramine in the diet (Jennings
et al. 1988; Turley et al. 1994, 1996). The inclusion of chitosan
and cellulose in the diet also significantly reduced hepatic choles-
terol concentrations, yielding values of 30 and 41 mg/g liver,
respectively (Table 1). The chitosan effect is consistent with data
in the literature (Jennings et al. 1988; Trautwein et al. 1997;
Gallaher et al. 2000). Hepatic total cholesterol stores, calculated
by multiplying the hepatic total cholesterol concentration
(mg cholesterol/g liver) by the liver weight, decreased by 94, 57
and 40 mg cholesterol per mouse for the cholestyramine, chitosan
and cellulose groups, respectively, relative to the total liver choles-
terol of the control group. The effects of dietary fibres on liver total
cholesterol levels were also reflected in their effects on hepatic
cholesteryl ester stores (Table 1): the cholesteryl ester pools were
significantly lower in animals fed cholestyramine-, chitosan- and
cellulose-containing diets, as compared with the control group.
The hepatic levels of cholesterol in the four animal groups
correlated with the appearance of the livers: livers of the control
group were light-coloured, those of mice fed the cholestyramine-
containing diet were normal, dark red and those of the chitosan
and cellulose groups were medium red-coloured.
Effects of dietary fibres on cholesterol and bile acid metabolism
In order to discriminate between decreases in cholesterol absorp-
tion and increases in cholesterol and bile acid excretion as poss-
ible mechanisms for the observed alterations in hepatic and serum
cholesterol levels (Table 1), we investigated the effects of the
dietary fibres on these parameters and on bile composition.
Cholestyramine caused a significant increase in faecal choles-
terol output from about 0·5 mg/d per g body weight in control
mice to about 1 mg/d per g body weight (Table 2). The other
fibres had no significant effect on daily faecal cholesterol
output. Faecal bile acid excretion levels averaged 3·3, 3·3 and
3·4mmol bile acid/d per body weight, respectively, in the control,
chitosan and cellulose groups, and were significantly increased to
5·3mmol bile acid/d per g body weight in the cholestyramine
group (Table 2). Cholestyramine also significantly affected the
concentrations of cholesterol and bile acids in the bile of the
mice. Thus, the biliary cholesterol level was in the range 16–
19 mM for the control, chitosan and cellulose groups but only
3 mM in the cholestyramine-fed animals (Table 2). Inclusion of
cholestyramine in the diet also reduced the biliary bile acid
level significantly to 107 mM relative to the control (354 mM;
Table 2). The biliary bile acid concentrations in the chitosan
and cellulose groups were not significantly different from that
of the control group. Biliary phospholipid concentrations aver-
aged about 42 mM for all groups (data not shown).
Since cholesterol balance in the enterohepatic circulation is
sensitive to the level of cholesterol acquired from food, we com-
pared the effects of the dietary fibres on cholesterol absorption
efficiency. The intestinal cholesterol absorption efficiency was
34 % in the control group and 22 % in the cholestyramine-fed
group (Table 2). The cholesterol absorption efficiencies in the
presence of chitosan and cellulose were identical within exper-
imental error to that of the control. The absence of an effect of
these fibres on cholesterol absorption efficiency was not due to
a delayed appearance of the radiolabels in the stool because
more than 95 % of the 3H-labelled sitostanol was recovered in
the faeces after 24 h (data not shown).
Effects of dietary fibres on body weight and food intake
Since the change from standard rodent chow to HFHC diet was
expected to increase body weight, this parameter was monitored
for the four groups of mice. At baseline, the mean body weights
were similar: 19·3 g/animal (control), 19·7 g/animal (cholestyra-
mine), 19·3 g/animal (chitosan) and 19·8 g/animal (cellulose).
The mice on the control HFHC diet showed the greatest gain in
weight over the 3-week diet period; the mean increase in
body weight was þ9·0 %. The increase in body weight in this
control group of mice was associated with the largest increase
in serum and liver cholesterol concentrations (Table 1). In
marked contrast, there was no increase in body weight of the
cholestyramine-treated group (20·2 %) and there was no change
in either serum cholesterol or hepatic cholesterol stores. Moderate
Table 1. Plasma and liver cholesterol concentrations*†
(Mean values, standard deviations and P values)
Diet groups
Control (n 6) Cholestyramine (n 6) Chitosan (n 6) Cellulose (n 6)
Parameter Mean SD Mean SD P Mean SD P Mean SD P
Serum cholesterol concentration (mM) 4·3 1·4 2·0 0·7 0·033 2·2 1·6 0·038 1·6 0·8 0·004
Hepatic total cholesterol concentration (mg/g liver) 72 19 2·9 0·3 ,0·001 30 16 ,0·001 41 17 0·006
Percentage of hepatic total cholesterol as cholesteryl ester 94 1 34 8 ,0·001 82 5 ,0·001 87 9 0·002
* The variables were compared between the group of control mice and each group of fibre-treated animals; P values were calculated using ANOVA followed by the Dunnett test.
† For details of diets and procedures, see p. 332.
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weight gains were observed in the chitosan-treated group
(þ3·1 %) and in the cellulose-treated group (þ2·1 %). In these
cases, the HFHC diet did not increase serum cholesterol although
it did increase hepatic cholesterol stores to levels intermediate to
those of the control and cholestyramine-treated groups (Table 1).
All mice appeared healthy and were active throughout the feeding
experiment.
As expected, the mean weight gain over the 3-week period of
the diet for each group of mice was a function of the correspond-
ing food intake. The dependence of weight increase (W, g/animal)
on steady-state food intake (F, g/animal) was described by the
equation W ¼ 1·38F 2 3·92 (r 2 0·8). There was an initial
period of adjustment to the new diets and during this time the
daily food intake fluctuated. However, for all groups of mice
the food intakes became quite constant for days 10–21 of the
diet regimen. Fig. 1 compares these steady-state daily food
intakes for the four groups of mice. It is apparent that inclusion
of the fibres in the diet reduced the food intake by about 15–
20 % relative to the control group in all cases. Since the intestinal
absorption efficiency was similar for the control, chitosan and
cellulose groups (Table 2), it follows that the amount of choles-
terol absorbed in the chitosan and cellulose groups of mice also
decreased by 15–20 % relative to the value for the control
group (about 16 mg cholesterol/mouse per d as calculated from
the food intake data in Fig. 1 and the cholesterol intestinal absorp-
tion efficiencies in Table 2). Since cholestyramine treatment not
only decreased food intake (Fig. 1) but also decreased cholesterol
absorption efficiency (Table 2), the overall effect of this fibre on
cholesterol uptake in the intestine was greater.
Discussion
The results of the present study show that inclusion of 7·5 % (w/w)
cholestyramine, chitosan and cellulose in the diet had significant
effects on the accumulation of dietary cholesterol in the mice.
The change from basal to HFHC diet increased the daily intestinal
absorption of dietary cholesterol for a control mouse from zero to
about 16 mg/d. Feeding of cholestyramine completely prevented
accumulation of this cholesterol in hepatic stores while feeding
of chitosan and cellulose partially prevented this accumulation
(Table 1). Several mechanistic theories for the hypocholesterolae-
mic effects of naturally occurring fibres have been put forward
(Furda, 1990). One such mechanism involves binding of bile acid
molecules in the intestinal lumen to the fibre, as occurs with choles-
tyramine. Such a mechanism would be expected to apply to a cat-
ionic polymer such as chitosan but not to a neutral fibre such as
cellulose. Indeed, there is some question as to whether the insoluble
cellulose fibre has any cholesterol-lowering effect (Chen & Ander-
son, 1979). A completely different mechanism of action of dietary
fibres may relate to their ability to suppress energy intake. Dietary
fibres can induce both satiation (i.e. limit the size of a meal) and
satiety (i.e. inhibit the desire for another meal) (Burton-Freeman,
2000). Both effects can reduce the intake of any cholesterol present
in the diet. Analysis of these cholesterol balance parameters for the
four groups of mice has enabled us to compare the contributions to
cholesterol reduction of the satiation and satiety-inducing proper-
ties and the bile acid-binding properties of the fibres.
Mechanisms of cholesterol-lowering effects of cholestyramine
Cholestyramine is a well-known resin that has been widely used
for the treatment of atherosclerosis and the prevention of CHD
(Brown, 1990). The cholesterol-lowering effect of this compound
(Table 1) has been clearly demonstrated in human and animal
studies (Gylling et al. 1989; Turley et al. 1994). As a result of
the extensive sequestration of bile acids in the intestines by cho-
lestyramine, the amount of recycled bile acids, usually in excess
of 95 % (Cohen, 1999), was dramatically reduced and the demand
Table 2. Intestinal and biliary cholesterol and bile acid parameters*†
(Mean values, standard deviations and P values)
Diet groups
Control (n 6) Cholestyramine (n 5) Chitosan (n 6) Cellulose (n 6)
Parameter Mean SD Mean SD P Mean SD P Mean SD P
Faecal excretion of cholesterol (mg/d per g body wt) 0·55 0·18 1·06 0·31 0·002 0·59 0·07 0·67 0·56 0·10 0·90
Faecal excretion of bile acids (mmol/d per g body wt) 3·3 1·4 5·3 0·5 0·003 3·3 0·8 0·95 3·4 0·5 0·64
Biliary cholesterol concentration (mM) 19 6 3 1·5 ,0·001 16 7 0·90 19 5 0·99
Biliary bile acid concentration (mM) 354 105 107 68 0·002 324 59 0·95 247 85 0·17
Cholesterol absorption efficiency (%) 34 8 22 12 0·05 36 6 0·99 33 8 0·99
* The variables were compared between the group of control mice and each group of fibre-treated animals; P-values were calculated using ANOVA followed by the Dunnett test.
† For details of diets and procedures, see p. 332.
Fig. 1. Effects of the dietary insoluble fibres on steady-state daily food intake.
Values are means (six mice per group) with standard deviations depicted by
vertical bars. The food intakes for the three fibre groups were significantly
lower than that of the control group (P,0·05).
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for hepatic cholesterol metabolism towards bile acid formation
and secretion in cholestyramine-fed mice was consistent with
the finding of lower biliary cholesterol and bile acid levels
(Table 2). Feeding cholestyramine reduced the cholesterol absorp-
tion efficiency significantly from 34 % in control mice to 22 %
(Table 2). This decrease was caused by the binding of bile
acids to cholestyramine in the intestinal lumen which results in
decreased cholesterol solubilization and reduced cholesterol
uptake at the brush border membrane of enterocytes (cf. Homan
& Krause, 1997). The binding of bile acids to cholestyramine
led to increased excretion of bile acids and cholesterol in the
faeces (Table 2) as has been found in human (Stanley et al.
1973) and other animal studies (Turley et al. 1996).
As a consequence of the changes, described earlier, in bile acid
availability in the lumen of the intestines, the amount of dietary
cholesterol absorbed was about 9 mg/mouse per d (calculated
from the food intake data in Fig. 1 and the cholesterol intestinal
absorption efficiencies in Table 2) in the cholestyramine group
compared to about 16 mg/mouse per d in the control group. In
the latter case, the 16 mg/mouse per d of absorbed cholesterol
was associated with an increase of about 90 mg/mouse in liver
cholesterol over the 3-week period (Table 1). This corresponds
to a rate of accumulation of liver cholesterol of about 4 mg/d,
with the excess being lost in the faeces as cholesterol or bile
acid. In the cholestyramine group, the 9 mg/mouse per d of
absorbed cholesterol did not lead to any accumulation of choles-
terol in the liver (Table 1) over the feeding period. The 90 mg
lower accumulation of liver cholesterol for the cholestyramine
group compared to the control group was due, in part, to enhanced
rates of loss of cholesterol and bile acid in the faeces (Table 2). It
should be noted that the combined serum and biliary cholesterol
pools amounted to about 1 mg/mouse and were relatively small
compared to the hepatic cholesterol pool. The cholesterol present
in adipose tissue was not assessed but this storage pool was prob-
ably not affected greatly during the feeding period because it
turns over slowly (Farkas et al. 1973).
It is important to note that there were two contributions to
the reduction in daily cholesterol absorption from 16 to 9 mg/
mouse per d when cholestyramine was included in the diet.
The decrease in daily cholesterol intake (calculated from the
food intake data in Fig. 1) would have reduced the amount
of absorbed cholesterol by about 2·4 mg/mouse per d if the
absorption efficiency had remained at 34 % (the value for con-
trol mice, see Table 2). The remainder of the 7 (16 2 9) mg/d
per mouse reduction in absorbed cholesterol in cholestyramine-
treated mice, i.e. about 4·6 mg/mouse per d, was a consequence
of the decrease in cholesterol absorption efficiency to 22 %.
Thus, about one-third (2·4/7) of the reduction in daily choles-
terol absorption arising from cholestyramine treatment was
due to satiation and satiety effects (cf. Burton-Freeman, 2000)
and two-thirds was due to bile acid sequestration effects.
Mechanisms of cholesterol-lowering effects of chitosan and
cellulose
In contrast to the cholestyramine-fed mice, there was no change
in cholesterol absorption efficiency or faecal sterol excretion
with the groups of mice fed either chitosan or cellulose
(Table 2). Hence, the hypocholesterolaemic effects (Table 1)
of both chitosan and cellulose cannot be rationalized in terms
of either a reduction in cholesterol absorption efficiency or a
significant increase in faecal sterol output. It follows that, in
contrast to the situation with cholestyramine, the hypocholester-
olaemic effects of chitosan and cellulose cannot be related to a
major bile acid-binding capacity of these two fibres. The mech-
anism of action of these two dietary fibres seems to be related
to a suppression of food intake by means of inducing satiation
and satiety (Burton-Freeman, 2000). Thus, the average food
intake of all three groups of mice receiving a dietary fibre
decreased significantly with respect to the control groups of
mice (Fig. 1). The daily amount of dietary cholesterol absorbed
in the chitosan and cellulose groups of mice was about 13 mg/
mouse in each case; this value was about 3 mg lower than the
16 mg/mouse per d seen with the control group. The daily
absorption of 13 mg cholesterol per mouse was associated
with accumulations of approximately 40 and 60 mg liver choles-
terol over 3 weeks for the chitosan and cellulose groups,
respectively (Table 1). It follows that the rates of accumulation
of liver cholesterol were about 2 and 3 mg/mouse per d com-
pared to the value of about 4 mg/mouse per d for the control
group. The lower rates of cholesterol accumulation in the
fibre-treated groups apparently were not due to differences in
rates of faecal output of cholesterol and bile acid (Table 2).
Overall, our results suggest that satiation and satiety effects
(Burton-Freeman, 2000) contributed significantly to the choles-
terol-lowering properties of dietary chitosan and cellulose seen
in these mice. This finding is consistent with an earlier study
(Trautwein et al. 1997) where it was shown that incorporation
of chitosan into the diet of hamsters led to a reduction in food
intake and a cholesterol-lowering effect.
Clinical implications
Mechanisms underlying the cholesterol-lowering effect of cho-
lestyramine are (1) decreased cholesterol (food) intake, (2)
decreased cholesterol absorption efficiency, and (3) increased
faecal bile acid and cholesterol excretion. The latter effects
can be attributed to the high bile acid-binding capacity of cho-
lestyramine. In contrast, incorporation of chitosan or cellulose
in the diet reduced cholesterol (food) intake, but did not signifi-
cantly affect either intestinal cholesterol absorption or faecal
sterol excretion in our study. We conclude that satiation and
satiety effects contribute to the cholesterol-lowering properties
of dietary fibres with moderate or low bile acid-binding capa-
bilities. Knowledge about the mechanisms by which the differ-
ent fibres prevent cholesterol accumulation will be helpful for
investigating clinical effects of fibre therapy. A possible ben-
eficial effect of fibres on cardiovascular risk might be related
to the different mechanisms by which the fibres influence
lipid metabolism. Thus, in future studies, the effect on cardio-
vascular morbidity and mortality as well as the occurrence of
side-effects should be evaluated separately for each kind of
fibre.
We have observed impressive effects of the fibres investigated
in the present study, e.g. the satiation and satiety effects of chit-
osan and cellulose were sufficient to stabilize serum cholesterol
levels against the increase induced by the HFHC diet, and
reduce the degree to which liver cholesterol stores are increased
by the HFHC diet. However, the dose of fibres used (7·5 % of
diet, w/w) was higher than doses usually used in human trials,
e.g. 2 % of chitosan incorporated into bread (Ausar et al. 2003)
or 3–6 g of chitosan applied daily as capsules (Maezaki et al.
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1993; Mhurchu et al. 2004). It should be noted that the cholesterol
concentration used in the present study (1·25 % of diet, w/w) was
much higher than the cholesterol content of diets usually con-
sumed by man. Hence, a fibre content below 7·5 % might be suf-
ficient to prevent cholesterol accumulation in man, as previously
shown for cholestyramine (Brown, 1990) and chitosan (Maezaki
et al. 1993; Pittler et al. 1999; Ylitalo et al. 2002; Bokura &
Kobayashi, 2003). Investigation of cellulose in clinical studies
is most intriguing, because a hypocholesterolaemic effect of cel-
lulose has not been established as clearly (Chen & Anderson,
1979), although intake of high concentrations of cellulose as a
food supplement in man was reported to lower serum cholesterol
by about 25 % (Shurpalekar et al. 1971).
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